 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
MDx/CDx Focus: Verastem, LabCorp Ink CDx Pact; Foundation Medicine Raises More Cash; and more
January 09, 2013
MDx/CDx Focus: Verastem, LabCorp Ink CDx Pact; Foundation Medicine Raises More Cash; and more
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- NCI Awards Contracts to Insight Genetics to Develop NSCLC CDx
November 12, 2012 / GenomeWeb Daily News - Insight Genetics Wins $1.5M Grant to Begin Clinical Testing for ALK Mutation CDx on Qiagen Platform
October 11, 2012 / PCR Insider - MDx/CDx Focus: Qiagen; Dako & Amgen; Ventana & Pfizer; Foundation Medicine & Sanofi; and More
January 11, 2012 / Pharmacogenomics Reporter - Qiagen Gains Approval in Japan for EGFR Companion Dx, Acquires Rights to New Markers
January 10, 2012 / GenomeWeb Daily News - Novartis, Cepheid Hope to Improve Bcr-Abl Transcript Monitoring in Gleevec-Treated CML Patients
October 13, 2010 / Pharmacogenomics Reporter